Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATPYoung Hee Ko, Peter L. Pedersen, Barbara L. Smith et al.|Biochemical and Biophysical Research Communications|2004Cited by 350
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M. Jaffee, Richard Sullivan, Chi V. Dang et al.|The Lancet Oncology|2017Cited by 209
Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma PatientsXiang Xu, Peter C.M. van Zijl, Guanshu Liu et al.|Tomography|2015Cited by 182
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine Zukotynski, Steven P. Rowe, Urban Emmenegger et al.|Journal of Nuclear Medicine|2021Cited by 52
Preclinical evaluation of <sup>213</sup>Bi-/<sup>225</sup>Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancerSangeeta Ray, Martin G. Pomper|Journal of Nuclear Medicine|2020Cited by 39